Solid Biosciences Inc. (SLDB)
NASDAQ·Healthcare·Biotechnology
$7.46
-0.53%
Mkt Cap $617.05M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | — | — | — | -$0.51 | -$0.50 | +1.96% | — | — |
| Q4 2025 Nov 3, 2025 | — | — | — | -$0.42 | -$0.48 | -14.29% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.51 | -$0.42 | +17.65% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.53 | -$0.59 | -11.32% | — | — |
| Q1 2025 Mar 6, 2025 | — | — | — | -$0.79 | -$0.89 | -12.66% | — | — |
| Q4 2024 Nov 6, 2024 | — | — | — | -$0.67 | -$0.79 | -17.91% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.68 | -$0.61 | +10.29% | — | — |
| Q2 2024 May 15, 2024 | $1.21M | — | — | -$0.57 | -$0.64 | -12.28% | — | — |
| Q1 2024 Mar 13, 2024 | — | $4.74M | — | -$1.01 | -$1.00 | +0.99% | — | — |
| Q4 2023 Nov 8, 2023 | $1.10M | — | — | -$1.20 | -$1.05 | +12.50% | — | — |
| Q3 2023 Aug 14, 2023 | $1.47M | — | — | -$1.52 | -$1.25 | +17.76% | — | — |
| Q2 2023 May 11, 2023 | $1.47M | — | — | -$1.83 | -$1.54 | +15.85% | — | — |
| Q1 2023 Mar 23, 2023 | $1.17M | $8.09M | +591.79% | -$2.70 | -$0.68 | +74.81% | — | — |
| Q4 2022 Nov 10, 2022 | $300.00K | — | — | -$2.59 | -$2.71 | -4.63% | — | — |
| Q3 2022 Aug 11, 2022 | $4.08M | $6.17M | +51.03% | -$3.15 | -$3.30 | -4.76% | — | — |
| Q2 2022 Apr 27, 2022 | $2.68M | $1.93M | -28.12% | -$2.70 | -$3.30 | -22.22% | — | — |
| Q1 2022 Mar 14, 2022 | $1.73M | $3.15M | +82.08% | -$3.00 | -$2.55 | +15.00% | — | — |
| Q4 2021 Nov 3, 2021 | $1.32M | $3.54M | +167.95% | -$2.85 | -$2.40 | +15.79% | — | — |
| Q3 2021 Aug 16, 2021 | $1.32M | $3.59M | +172.27% | -$2.70 | -$2.55 | +5.56% | — | — |
| Q2 2021 May 14, 2021 | $4.22M | $3.33M | -20.99% | -$4.20 | -$2.85 | +32.14% | — | — |